Long-term use of antibiotics and risk of colorectal adenoma

Gut

Volumn 67, Issue 4, 2018, Pages 672-678

  Cao, Yin ^a,b   Wu, Kana ^b   Mehta, Raaj ^a   Drew, David A ^a   Song, Mingyang ^a,b   Lochhead, Paul ^a   Nguyen, Long H ^a   Izard, Jacques ^c   Fuchs, Charles S ^d,e,f   Garrett, Wendy S ^b,g,h   Huttenhower, Curtis ^b,h   Ogino, Shuji ^b,g,i   Giovannucci, Edward L ^b,i   Chan, Andrew T ^a,h,i  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^d YALE CANCER CENTER   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Smilow Cancer Hospital   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

^h BROAD INSTITUTE OF MIT AND HARVARD   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ANTIBIOTICS; COLONIC MICROFLORA; COLORECTAL ADENOMAS; INFLAMMATION

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CANCER RISK; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL ADENOMA; CONTROLLED STUDY; DRUG USE; FEMALE; HIGH RISK PATIENT; HISTOLOGY; HUMAN; LONG TERM CARE; LOW RISK PATIENT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR VOLUME; ADENOMA; CHEMICALLY INDUCED; COLORECTAL TUMOR; MIDDLE AGED; NURSING; NURSING RESEARCH; PATHOLOGY; PREDICTIVE VALUE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TIME FACTOR; UNITED STATES;

ADENOMA; ADULT; ANTI-BACTERIAL AGENTS; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NURSING RESEARCH; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; UNITED STATES;

EID: 85026767479     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-313413     Document Type: Article

References (34)

1. Lee GC, Reveles KR, Attridge RT, II, et al. Outpatient antibiotic prescribing in the United States: 2000 to 2010. BMC Med 2014;12:96.
2. Scribano ML, Prantera C. Antibiotics and inflammatory bowel diseases. Dig Dis 2013;31:379-84.
3. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis. Am J Gastroenterol 2011;106:2133-42.
4. Canova C, Zabeo V, Pitter G, et al. Association of maternal education, early infections, and antibiotic use with celiac disease: a population-based birth cohort study in northeastern Italy. Am J Epidemiol 2014;180:76-85.
5. Cox LM, Yamanishi S, Sohn J, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 2014;158:705-21.
6. Bailey LC, Forrest CB, Zhang P, et al. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr 2014;168:1063-9.
7. Jakobsson HE, Jernberg C, Andersson AF, et al. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE 2010;5:e9836.
8. Sommer MO, Dantas G, Church GM. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 2009;325:1128-31.
9. Ianiro G, Tilg H, Gasbarrini A. Antibiotics as deep modulators of gut microbiota: between good and evil. Gut 2016; doi:10. 1136/gutjnl-2016-312297. [Epub ahead of print 16 Aug 2016].
10. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 2014;12:661-72.
11. Flemer B, Lynch DB, Brown JM, et al. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut 2016;doi:10. 1136/ gutjnl-2015-309595. [Epub ahead of print 18 Mar 2016].
12. Nakatsu G, Li X, Zhou H, et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat Commun 2015;6:8727.
13. Jernberg C, Löfmark S, Edlund C, et al. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology (Reading, Engl) 2010;156:3216-23.
14. Lange K, Buerger M, Stallmach A, et al. Effects of antibiotics on gut microbiota. Dig Dis 2016;34:260-8.
15. Blaser MJ. Antibiotic use and its consequences for the normal microbiome. Science 2016;352:544-5.
16. Kilkkinen A, Rissanen H, Klaukka T, et al. Antibiotic use predicts an increased risk of cancer. Int J Cancer 2008;123:2152-5.
17. Boursi B, Haynes K, Mamtani R, et al. Impact of antibiotic exposure on the risk of colorectal cancer. Pharmacoepidemiol Drug Saf 2015;24:534-42.
18. Dik VK, van Oijen MG, Smeets HM, et al. Frequent use of antibiotics is associated with colorectal cancer risk: results of a nested case-control study. Dig Dis Sci 2016;61:255-64.
19. Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012;143: 844-57.
20. McCullough ML, Feskanich D, Stampfer MJ, et al. Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr 2002;76:1261-71.
21. Chiuve SE, Fung TT, Rimm EB, et al. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr 2012;142:1009-18.
22. Wang JL, Chang CH, Lin JW, et al. Infection, antibiotic therapy and risk of colorectal cancer: a nationwide nested case-control study in patients with Type 2 diabetes mellitus. Int J Cancer 2014;135:956-67.
23. Dethlefsen L, Huse S, Sogin ML, et al. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008;6:e280.
24. Jernberg C, Löfmark S, Edlund C, et al. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. Isme J 2007;1:56-66.
25. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. P Natl Acad Sci USA 2011;108(Suppl 1):4554-61.
26. Abreu MT, Peek RM Jr. Gastrointestinal malignancy and the microbiome. Gastroenterology 2014;146:1534-46. e3.
27. Wang TT, Cai GX, Qiu YP, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2012;6:320-9.
28. Modi SR, Collins JJ, Relman DA. Antibiotics and the gut microbiota. J Clin Invest 2014;124:4212-18.
29. Castellarin M, Warren RL, Freeman JD, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012;22:299-306.
30. Ahn J, Sinha R, Pei Z, et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 2013;105:1907-11.
31. Kostic AD, Gevers D, Pedamallu CS, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012;22:292-8.
32. den Besten G, van Eunen K, Groen AK, et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 2013;54:2325-40.
33. Terzi J, Grivennikov S, Karin E, et al. Inflammation and colon cancer. Gastroenterology 2010;138:2101-14. e5.
34. Laiyemo AO, Doubeni C, Sanderson AK II, et al. Likelihood of missed and recurrent adenomas in the proximal versus the distal colon. Gastrointest Endosc 2011;74:253-61.